Pharmacovigilance

Pharmacovigilance is at the heart of every product Agio Pharmaceuticals brings into the global market. While clinical trials establish the safety and efficacy of a medicine before approval, real-world use across diverse populations and longer time horizons can reveal effects that smaller trial settings simply cannot capture. 

Agio Pharmaceuticals maintains a structured pharmacovigilance framework designed to monitor, assess, and respond to product safety throughout its life cycle. This includes systematic tracking of adverse events, ongoing evaluation of emerging safety signals, and timely communication of risk-related information to healthcare professionals and regulatory authorities, in accordance with applicable regulatory requirements.

This continuous vigilance, aligned with international regulatory expectations across the 30+ countries we serve, reflects our deeper commitment and trust earned from the medical fraternity.